Article

LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4‑mediated MAPK signal pathway

2021-01-21

Abstract excerpt

<h4>Background: </h4> Adriamycin (ADR) resistance is one of the main obstacles to improving the clinical prognosis of breast cancer patients. Long noncoding RNAs (lncRNAs) can regulate cell behavior, but the role of these RNAs in the anti-ADR activity of breast cancer remains unclear. Here, we aim to investigate the imbalance of a particular long noncoding RNA, lncRNA CBR3 antisense RNA 1 (CBR3-AS1), and its role...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 669bc200-aaf0-5f00-8d70-1a5032ac0552
DOI: 10.21203/rs.3.rs-54834/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4‑mediated MAPK signal pathwayDOI 10.21203/rs.3.rs-54834/v2Read

LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasionSemantic proximity Read

LncRNA FLVCR1-AS1 promotes proliferation, migration and activates Wnt/β-catenin pathway through miR-381-3p/CTNNB1 axis in breast cancerSemantic proximity Read

Long Non-coding RNA CBR3-AS1 Mediates Tumorigenesis and Radiosensitivity of Non-small Cell Lung Cancer through Redox and DNA Repair by CBR3-AS1 /miR-409-3p/SOD1 AxisSemantic proximity Read

RERE-AS1 enhances the effect of CDK4/6 inhibitor Ribociclib and suppresses malignant phenotype in breast cancer via MEK/ERK pathway.Semantic proximity Read

Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis.Semantic proximity Read

Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast CancerSemantic proximity Read

LRP11-AS1 Promotes the Malignant Behavior of Triple Negative Breast Cancer Cells via the MiR-149-3p/NRP2 AxisSemantic proximity Read

The Role of Drug Resistance Causing lncRNAs in Breast Cancer: In-silico AnalysisSemantic proximity Read

Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN LossSemantic proximity Read

A Novel Tumor Suppressor ASMTL-AS1 Regulates the Mir-1228-3p/SOX17/Β-Catenin Axis in Triple-Negative Breast CancerSemantic proximity Read

LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancerSemantic proximity Read

LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570–3pSemantic proximity Read